Company: LBRX
Filing Date: 2025-09-12
Form Type: 8-K
Source: 0001193125-25-202195
Chunk: 0

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-09-12
Form: 8-K
Item: Item 5.03
Chunk 0
---
Item 5.03      Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.  

Amendment and Restatement of Certificate of Incorporation

In connection with the closing of the initial public offering of shares of common stock (the “ IPO”) of LB Pharmaceuticals Inc (the “ Company”) on September 12, 2025, the Company filed an amended and restated certificate of incorporation (the “ Restated Certificate”) with the Secretary of State of the State of Delaware. The Company’s board of directors (the “ Board”) and stockholders previously approved the Restated Certificate to be effective as of immediately prior to the closing of the IPO.

Amendment and Restatement of Bylaws

Effective as of September 12, 2025, the Company adopted amended and restated bylaws (the “ Restated Bylaws”) in connection with the closing of the IPO. The Board and stockholders previously approved the Restated Bylaws to be effective immediately prior to the closing of the IPO.

The foregoing descriptions of the Restated Certificate and Restated Bylaws are qualified in their entirety by reference to the full text of the Restated Certificate and Restated Bylaws, which are filed as Exhibits 3.1 and 3.2 hereto, respectively, and are incorporated herein by reference.